EMA
guidance
· 2009-09-25
Supply shortage of Fabrazyme – updated treatment recommendations required for adult male patients
Summary
EMA updates treatment recommendations for Fabrazyme due to supply shortage, focusing on adult male patients.
Upgrade for the full analysis, importance score, and drug timeline.